Search

Displaying results 7351 - 7360 of 10000 in total
  1. Drug

    Emorfazone

    go.drugbank.com/drugs/DB21286
    Experimental

    Emorfazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Emorfazone is a anti-inflammatory analgesic, phenylbutazone derivative.

  2. Drug

    Fibracillin

    go.drugbank.com/drugs/DB21302
    Experimental

    Fibracillin is a small molecule drug. The usage of the INN stem '-cillin' in the name indicates that Fibracillin is a antibiotic, 6-aminopenicillanic acid derivative.

  3. Drug

    Ipazilide

    go.drugbank.com/drugs/DB21330
    Experimental

    Ipazilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ipazilide is a sematilide derivative class III antiarrhythmic.

  4. Drug

    Pidobenzone

    go.drugbank.com/drugs/DB21369
    Experimental

    Pidobenzone is a small molecule drug. The usage of the INN stem '-zone' in the name indicates that Pidobenzone is a anti-inflammatory analgesic, phenylbutazone derivative.

  5. Drug

    Trifezolac

    go.drugbank.com/drugs/DB21380
    Experimental

    Trifezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Trifezolac is a anti-inflammatory agent, ibufenac derivative.

  6. Drug

    Pulrodemstat

    go.drugbank.com/drugs/DB21497
    Experimental

    Pulrodemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor.

  7. Drug

    Zavolosotine

    go.drugbank.com/drugs/DB21531
    Experimental

    Zavolosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist.

  8. Drug

    Branosotine

    go.drugbank.com/drugs/DB21674
    Experimental

    Branosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist.

  9. Drug

    Rocakinogene sifuplasmid

    go.drugbank.com/drugs/DB16316
    Investigational

    Rocakinogene sifuplasmid is under investigation in clinical trial NCT03491683 (INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-diagnosed Glioblastoma

  10. Drug

    Chiauranib

    go.drugbank.com/drugs/DB16124
    Investigational

    Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).